FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32963311000001100: Selexipag 200microgram tablets 10 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100473501000001115 Selexipag 200microgram tablets 10 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100473601000001116 Selexipag 200microgram tablets 10 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Selexipag 200microgram tablets 10 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet Has VMP Selexipag 200microgram tablets true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet Has specific active ingredient Selexipag false Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Selexipag 200microgram tablets 10 tablet Has specific active ingredient Selexipag true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Uptravi 200microgram tablets (Janssen-Cilag Ltd) 10 tablet Is a True Selexipag 200microgram tablets 10 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start